Cargando…
Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis
Pulmonary fibrosis is characterized by the remodeling of fibrotic tissue and collagen deposition, which mainly results from aberrant fibroblasts proliferation and trans-differentiation to myofibroblasts. Patients with chronic myelogenous leukemia, myeloproliferative disorder, and scleroderma with pu...
Autores principales: | Zhou, Yan, Zhang, Bo, Li, Chen, Huang, XiaoTing, Cheng, HaiPeng, Bao, XingWen, Zhao, FeiYan, Cheng, QingMei, Yue, ShaoJie, Han, JianZhong, Luo, ZiQiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733875/ https://www.ncbi.nlm.nih.gov/pubmed/31501415 http://dx.doi.org/10.1038/s41419-019-1903-8 |
Ejemplares similares
-
NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2018) -
NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015) -
Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis
por: Zhao, Feiyan, et al.
Publicado: (2019) -
N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence
por: Huang, Pu, et al.
Publicado: (2022) -
Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Liu, Wei, et al.
Publicado: (2013)